RNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to ...

HSINCHU (dpa-AFX) - Die ungebrochen starke Nachfrage nach Computer-Hardware zum Ausbau der KI-Fähigkeiten der Techkonzerne hat dem Chiphersteller TSMC Ende 2024 einen Gewinnsprung beschert. Der weltgr ...

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches ...

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

Damit lief es für das Unternehmen mit dem vollen Namen Taiwan Semiconductor Manufacturing Company noch besser als von Analysten erwartet. Diese Entwicklung unterstützt die Erwartung, dass große ...

The GBA has not only mirrored the nation's transformation from a world factory to a smart manufacturing hub, but has also incubated 70 unicorn companies — startups valued at over $1 billion each.

BioNTech (BNTX) is presenting its 2025 strategic priorities and progress on the company’s pipeline of mRNA therapeutics, immunomodulators, and ...

Truist sets BioNTech's price target at $172, highlighting BNT327's revenue potential of $6B+ across multiple cancer indications. BioNTech's BNT327 could lead U.S. and European approvals for key ...

Furthermore, a need for manufacturing reliability in an increasingly uncertain geopolitical environment is pushing more companies to examine manufacturing closer to home. Unfortunately ...

The mileage covered by trucks with four or more axles, which are subject to toll charges, on German motorways increased by 0.5% in December 2024 compared with November 2024, after calendar and ...

German pharmaceutical company BioNTech has agreed to pay a combined sum of more than $1.2 billion to resolve separate disputes over royalty payments related to its COVID-19 vaccine. https://p.dw ...

BioNTech and its partner US pharmaceutical giant Pfizer are to pay a total of a €1.2 billion ($1.3 billion) to the US health agency and the University of Pennsylvania, BioNTech said. The ...